- Home
- INHD vs TPST Comparison
INHD vs TPST Comparison
Compare INHD & TPST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | INHD | TPST |
|---|---|---|
| Founded | 2019 | 2011 |
| Country | Hong Kong | United States |
| Employees | N/A | N/A |
| Industry | | Biotechnology: Pharmaceutical Preparations |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 9.6M | 11.1M |
| IPO Year | 2023 | 2012 |
Fundamental Metrics
Financial Performance| Metric | INHD | TPST |
|---|---|---|
| Price | $1.07 | $2.16 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $10.00 |
| AVG Volume (30 Days) | ★ 120.3K | 53.4K |
| Earning Date | 05-01-2026 | 03-24-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 17.61 | ★ 21.47 |
| EPS | ★ N/A | N/A |
| Revenue | ★ $2,846,250.00 | $295,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 221.43 | N/A |
| 52 Week Low | $0.06 | $0.60 |
| 52 Week High | $15.90 | $12.22 |
Technical Indicators
Market Signals| Indicator | INHD | TPST |
|---|---|---|
| Relative Strength Index (RSI) | 46.91 | 41.83 |
| Support Level | $1.07 | $2.14 |
| Resistance Level | $1.18 | $2.49 |
| Average True Range (ATR) | 0.06 | 0.12 |
| MACD | 0.01 | 0.01 |
| Stochastic Oscillator | 40.54 | 29.07 |
Price Performance
Historical ComparisonAbout INHD Inno Holdings Inc.
Inno Holdings Inc is a building technology company with a mission to transform the construction industry with its proprietary cold-formed steel-framing technology and other innovations. It is a manufacturer of cold-formed-steel members and prefabricated homes. It offers a full range of services required to transform raw materials into precise steel framing products and prefabricated homes. The company sells these finished products either to businesses or directly to customers. The finished products and cold-formed-steel members are used in a variety of building types, including residential, commercial, industrial and infrastructure.
About TPST Tempest Therapeutics Inc.
Tempest Therapeutics Inc is a late-stage develpment biotechnology company developing small molecule therapeutics to treat cancer through mechanisms that directly kill tumor cells and activate tumor-specific immunity. Its clinical-stage therapeutic product candidates are TPST-1120 and TPST-1495 which are clinical-stage molecules designed to inhibit their respective targets.